Triazole compounds useful in treating diseases associated with unwanted cytokine activity

Details for Australian Patent Application No. 2002338522 (hide)

Owner The Procter & Gamble Company

Inventors Tullis, Joshua Spector; Blass, Benjamin Eric; Clark, Michael Philip; Natchus, Michael George; Van Rens, John Charles; De, Biswanath

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002338522

PCT Number PCT/US02/13075

PCT Pub. Number WO2002/088113

Priority 60/287,604 30.04.01 US

Filing date 25 April 2002

Wipo publication date 11 November 2002

Acceptance publication date 15 December 2005

International Classifications

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 407/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 60/287,604 30.04.01 US

17 April 2003 Application Open to Public Inspection

  Published as AU-B-2002338522

15 December 2005 Application Accepted

  Published as AU-B-2002338522

13 April 2006 Standard Patent Sealed

20 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002338523-METHOD FOR DISSOLVING CARBON NANOTUBES

2002338521-Method for treating tumors by the administration of tegaf, uracil, folinic acid, and cyclophisphamide